Association Between Prescription Drug Monitoring Program Use Mandate and Opioid Prescribing and Patient-reported Outcomes After Surgery
Authors' conclusion
Following the implementation of Michigan's PDMP use mandate, the duration of opioid prescriptions decreased, but patient-reported outcomes did not worsen.
Study context
- Population
- Adults undergoing general surgical procedures, Michigan, January 2017 to October 2019
- Participants
- 21,897 adults
- Exposure
- After vs before Michigan's prescription drug monitoring program (PDMP) use mandate
- Outcome
- Monthly mean days supplied in dispensed opioid prescriptions (filled within 3 days of discharge)
Methodological detailsstatewide surgical registry linked to PDMP database, segmented regression
- Statewide surgical registry linked to PDMP database
- Segmented regression
Main finding
As reported in the abstract
Mean days supplied in dispensed opioid prescriptions (level change at mandate)
Mandate associated with level decrease in mean days supplied in dispensed opioid prescriptions
−0.5
95% CI −0.8, −0.2
Observational data: associations, not effects.
Further findings
Patient-reported outcomes (pain in week after surgery, care satisfaction, regret)
- Mandate not associated with worsened patient-reported outcomes
Patients with Narx scores ≥200 (subgroup)
- Findings similar among patients with Narx scores ≥200
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Association Between Prescription Drug Monitoring Program Use Mandate and Opioid Prescribing and Patient-reported Outcomes After Surgery. Ann Surg. Published 8 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →